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Abstract
The concepts and methods of Systems Biology are being extended to neuropharmacol-
ogy, to test and design drugs against neurological and psychiatric disorders. Computa-
tional modeling by integrating compartmental neural modeling technique and detailed
kinetic description of pharmacological modulation of transmitter - receptor interaction
is offered as a method to test the electrophysiological and behavioral effects of putative
drugs. Even more, an inverse method is suggested as a method for controlling a neural
system to realize a prescribed temporal pattern. In particular, as an application of the
proposed new methodology a computational platform is offered to analyze the gener-
ation and pharmacological modulation of theta rhythm related to anxiety is analyzed
here in more detail.
2
1 Introduction
Systems Biology is an emergent movement to combine system level description with
microscopic details. It might be interpreted as the renaissance of cybernetics [1] and
of system theory [2], materialized in the works of Robert Rosen [3]. (For an excellent
review on applying the system theoretical tradition to the new Systems Biology see
[4].)
To have a system-level understanding of biological systems [5, 6] we should get
information from five key features:
Architecture. The structure (i.e. units and relations among these units) of the system
from network of gene interactions via cellular networks to the modular architec-
ture of the brain are the basis of any system level investigations.
Dynamics. Spatio-temporal patterns (i.e. concentrations of biochemical components,
cellular activity, global dynamical activities such as measured by electroencephalo-
gram, EEG) characterize a dynamical system. To describe these patterns dynami-
cal systems theory offers a conceptual and mathematical framework. Bifurcation
analysis and sensitivity analysis reveal the qualitative and quantitative changes
in the behavior of the system.
Function. This is the role that units (from proteins via genes, cells and cellular net-
works) play to the functioning of a system (e.g. our body and mind).
Control. There are internal control mechanisms which maintain the function of the
system, while external control (such as chemical, electrical or mechanical per-
turbation) of an impaired system may help to recover its function.
Design. There are strategies to modify the system architecture and dynamics to get a
desired behavior at functional level. A desired function may be related to some
“optimal temporal pattern”.
While Systems Biology is now generally understood in a somewhat restricted way
for proteins and genes, its conceptual and mathematical framework could be extended
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to neuroscience, as well. Trivially, there is a direct interaction between molecular and
mental levels: chemical drugs influence mood and state of consciousness. However,
“almost all computational models of the mind and brain ignore details about neuro-
transmitters, hormones, and other molecules.” [7].
In this paper we show how to realize the program of Systems Biology in the context
of a new, dynamic neuropharmacology, which was outlined recently elsewhere [8].
Also, we offer a methodology to integrate conventional neural models with detailed
description of neurochemical synaptic transmission in order to develop a new strategy
for drug discovery. The procedure is illustrated on the problem of finding selective
anxiolytics.
In particular, our proposed working hypothesis is that
• for given putative anxiolytic drugs we can test their effects on the EEG curve by,
• starting from pharmacodynamic data (i.e. from dose-response plots), which of
course are different for different recombinant receptors,
• setting the kinetic scheme and a set of rate constants,
• simulating the drug-modulated GABA – receptor interaction,
• calculating the generated postsynaptic current,
• integrating the results into the network model of the EEG generating mechanism,
• simulating the emergent global electrical activity,
• evaluating the result and to decide whether the drug tested has a desirable effect.
In section 2 we first review the literature and existing computer models of anxiety
and anxiolytics. Second a review of GABA – GABAA (ligand – receptor) interaction
is given with a particular attention on its connection to anxiety research. In section 3
we elaborate on the proposed working hypothesis and give an example by integrating
a GABAAreceptor model by Bai et al. (1999)[9] into a gamma related theta generating
interneuron network model by Orba´n et al. (2001) [10].
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2 Computer models of anxiety
2.1 Biologically motivated modeling of neural circuits
2.1.1 Architecture: the septo-hippocampal system
It was demonstrated (see e.g. the seminal book of Gray and McNaughton [11]) that the
septo-hippocampal system is strongly involved in anxiety and related disorders.
In a joint pharmacological and computational work [12, 13] effects of the injection
of the positive and negative GABAA allosteric modulators diazepam and FG-7142, re-
spectively, were studied. To investigate the dynamical and functional effects of dif-
ferent pharmacological agents by computational tools a skeleton model of the septo-
hippocampal system was established. The skeleton network model (Fig. 1) of the hip-
pocampal CA1 region and the septal GABAergic cells consisted of five cell popula-
tions. The hippocampal CA1 pyramidal cell model was a multicompartmental model
modified from [14]. In the hippocampal CA1 region basket neurons and two types of
horizontal neurons were also taken into account.
[Figure 1 about here.]
Connections within and among cell populations were created faithfully following
the hippocampal structure. The main excitatory input to horizontal neurons is provided
by the pyramidal cells via AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid) mediated synapses [15]. Synapses of the septally projecting horizontal cells [16]
and synapses of the other horizontal cell population, the O-LM cell population inner-
vating distal apical dendrites of pyramidal cells [17] are of the GABAA type. O-LM
neurons (on of the two horizontal interneurons) also innervate parvalbumin contain-
ing basket neurons [18]. Basket neurons innervate pyramidal cells at their somatic
region and other basket neurons [19] as well. Septal GABAergic cells innervate other
septal GABAergic cells and hippocampal interneurons [20, 21] (Fig. 1). For a full
description of this model see the online supplementary materials to the paper [12] at:
http://geza.kzoo.edu/theta/theta.html.
The above described model captures several elements of the complex structure of
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the hippocampal CA1 and can be used to account for very precise interactions within
this region. However, when the focus of interest is rather on general phenomena tak-
ing place during rhythm generation modelers might settle for a simpler architecture.
In [10] authors describe gamma related theta oscillation generation in the CA3 region
of the hippocampus. The architecture of the model is exceedingly simplified: only an
interneuron network is simulated in detail. This simplification, however, allowed the
authors to introduce an extrahippocampal input and study its effect on rhythm gener-
ation. As a result, the model is able to account for basic phenomena necessary for
the generation of gamma related theta oscillation. As an extension of this model, au-
thors show [22] that activity of the interneuron network indeed accounts for rhythm
generation in pyramidal neurons.
2.1.2 Dynamics: Generation of theta rhythms
Theta frequency oscillation of the septo-hippocampal system has been considered as a
prominent activity associated with cognitive function and affective processes. To inves-
tigate the generation and control of theta oscillation in the hippocampal CA1 region the
previously described detailed, realistic model [12] was used. Firing of neurons of the
four simulated populations were modulated in time. There are time intervals in which
firing was significantly reduced were alternated by intervals where enhanced firing was
observed. This synchronized state of neural firing was further confirmed by the field
potential, which exhibited a prominent≈5 Hz oscillation (see Fig. 6 in [12]).
Simulation results showed that key components in the regulation of the popula-
tion theta frequency are the membrane potential oscillation frequency of pyramidal
cells, strength of the pyramidal cell – O-LM cell innervation and the strength of recur-
rent basket cell connections. Amplitude and frequency of pyramidal cell membrane
potential oscillation is determined by their average depolarization, passive membrane
parameters and parameters of the active currents. Average depolarization in our model
results from septal cholinerg innervation. An important factor is the presence and max-
imal conductance of the hyperpolarization activated current. If Ih is present it shortens
response times of pyramidal cells to hyperpolarizing current pulses and more impor-
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tantly decreases its variance: Ih acts as a frequency stabilizer. Synaptic strengths in our
description are set by convergence numbers and maximal synaptic conductances.
An explanation of intrahippocampal theta oscillation generation – based on this
model – includes (i), signal propagation in the pyramidal cell→ O-LM cell→ basket
cell → pyramidal cell feed-back loop, (ii), synchronization of neural activity via the
recurrent, inhibitory GABAA connections within the basket cell network and (iii), syn-
chronization of pyramidal cell firing due to rebound action potential generation. It is
true that the propagation of a single signal throughout this trisynaptic loop would not
require the amount of time characteristic to the theta oscillation (≈0.2–0.25 sec), thus
in the present case the population oscillation is created not by the propagation of single
signals but rather the propagation of a “synchronized state” in the network.
The observed periodic population activity is brought about by alternating synchro-
nization and desynchronization of cell activities due to the interplay of the above men-
tioned synchronizing forces and some desynchronizing forces (such as heterogeneity
of cell parameters and diversity of synaptic connections), as observed in [10, 22].
2.1.3 Function: Mood Regulation
The hippocampal formation is known to be involved in cognitive processes (navigation
and memory formation – for reviews see e.g. [23, 24]) and mood regulation [11, 25].
When an impairment occurs in the architecture or dynamics of the septo-hippocampal
system, this change is reflected in its function e.g. as an impairment of its memory
storing or mood regulatory capability. One such mood disorder is anxiety:
“Anxiety is a complex combination of the feeling of fear, apprehension and worry
often accompanied by physical sensations such as palpitations, chest pain and/or short-
ness of breath. It may exist as a primary brain disorder or may be associated with other
medical problems including other psychiatric disorders. . .
A chronically recurring case of anxiety that has a serious affect on your life may be
clinically diagnosed as an anxiety disorder. The most common are Generalized anx-
iety disorder, Panic disorder, Social anxiety disorder, phobias, Obsessive-compulsive
disorder, and post-traumatic stress disorder” [26]
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It is well documented that anxiolytics and hypnotics reduce the amplitude of septo-
hippocampal oscillatory theta activity, which contributes to their therapeutic effect but
causes unwanted side effects, e.g. cognitive impairment as well [27, 28].
Historically used mood regulators act on the barbiturate or benzodiazepine (BZ)
sites of GABA receptors. These drugs have both anxiolytic and hypnotic activity be-
cause they modulate all types of GABAA receptors.
Conventional anti-anxiety drugs have sedative-hypnotic side effects, and have neg-
ative effects on cognitive functions, such as memory and generally they reduce the am-
plitude of theta rhythm. While it seems possible to dissociate sedative-hypnotic effects
and anxiety, it is not clear how to decrease anxiety without impairing memory function.
Models of anxioselective actions: search for data
Recently it became clear that α subunits of GABAA receptors exhibit a remarkable
functional specificity. Genetic manipulations helped to show that α1 subunits are re-
sponsible for mediating sedative effects, while α2 subunits mediates anxiolytic effects
[29]. Preliminary experimental data and modelling studies for the effects of the pref-
erential GABAA α1 and α2 positive allosteric modulator, zolpidem and L838,417, re-
spectively, for the septo-hippocampal theta activity have been reported [30].
In that study we examined the effects of the α1 and α2 subtype-selective BZ site
ligand zolpidem and L838,417 on the septo-hippocampal system. In electrophysiolog-
ical experiments extracellular single unit recordings were performed from medial sep-
tum/diagonal band of Broca with simultaneous hippocampal (CA1) electroencephalo-
gram (EEG) recordings from anesthetized rats. Both of the drugs eliminated the hip-
pocampal theta oscillation, and turned the firing pattern of medial septal cells from
periodic to aperiodic, but only the zolpidem reduced the firing rate of the these neu-
rons. In parallel to these experimental observations, a computational model has been
constructed to clearly understand the effect of these drugs on the medial septal pace-
maker cells. We showed that the aperiodic firing of hippocampo-septal neurons can
reduce the periodicity of the medial-septal cells, as we have seen in the case of the
L838,417. The reduction of firing rates in the case of zolpidem is attributed to the
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increase of the synaptic conductances and the constant inhibition of these cells. We
modelled these drug effects by modifying (i) the synaptic maximal conductances of the
GABA synapses. (ii) the constant excitatory drive of the median septal cells and (iii)
the hippocampal input. The incorporation of a more detailed synaptic model, similarly
to the one proposed in Section 3.1, taking into account differences between α1 and α2
subunits is in progress.
Zolpidem increases by concentration-dependentmanner the duration and amplitude
of the postsynaptic current, most likely by enhancing the affinity of the receptors for
GABA [31], but these effects were diminished or absent in neurons from α1 knock-out
mice [32]
There seem to be compounds, which might have comparable binding affinity but
different efficacies at the various subtypes, thereby preferentially exerting their effects
at subtypes thought to be associated with anxiety. L838,417 seems to be an example for
subtype selective compounds [33], but only few kinetic or even pharmacodynamic data
could be found in the public domain. In Section 3 drugs whose effect on the GABA ki-
netics is known will be used to demonstrate the proposed methodology, using a detailed
kinetic model of GABA receptors within the network model of CA3 interneurons.
2.2 Phenomenological and kinetic descriptions of synaptic interac-
tion
2.2.1 Control: GABA receptor kinetics
Pharmacological modulation: why and how?
One perspective of the pharmacotherapy of anxiety might be based on reducing septo-
hippocampal theta activity and it is related to modulate the interaction between the
GABA transmitter and GABAA receptors. Since GABAA receptors occur in a variety
of specific forms, they might be subject of pharmacological control to obtain selective
functional effects. While by-and-large it is understandable that putative drugs induce
opening and closing of synaptic channels (here the chloride channels), the underlying
finely tuned kinetic mechanism of the interaction of transmitters, modulatory agents
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and receptors are not known. Our longer term goal is to find out how pharmacologi-
cal effects depend on the concentration of transmitter and of modulators. In technical
terms, while there are detailed models of the presynaptic transmitter release here we
restrict ourselves to build a detailed kinetic model for the generation of the postsynap-
tic response.
Pharmacological elements
Receptor Structure: GABAA receptors are pentameric structures consisting of multi-
ple subunits. At this moment [34] nineteen subunits have been cloned from mammalian
brain. According to their sequence similarities, subunits have been grouped into seven
families: α,β, γ, δ, ǫ, π and θ. Only a few dozen among the many combinatorial pos-
sibilities exist. The most frequent subtypes are two α, two β and one γ subunits. The
structural variations imply functional consequences [34], among others for the kinetic
properties.
Pharmacodynamics: Effect of drugs can be characterized by dose-response curves.
Some drugs have the ability to open a certain ion channel per se. In this case drugs are
characterized by the maximal evoked response or the potency, the drug concentration,
which elicit 50 % of the maximal response.
There are other cases, however, when the drug can not open the ion channel directly
but requires an additional ligand to evoke an action. In the followings we study drugs
that modulate interaction between the GABA transmitter and GABAA receptors.
Both barbiturates and BZs shift the GABA concentration-response curve to the left,
but barbiturates also increase the maximum response. They act on different states, con-
sequently they have different kinetic effects: average open time of the channel, but not
the channel opening frequency is increased significantly by barbiturates. As opposed
to BZs, barbiturate receptors do not contain γ subunits (see later). One more differ-
ence is that at high concentration GABA receptor channels can directly be opened by
barbiturates. For a summary see [35]. Anxiolytic activity was not a particular disad-
vantage when these drugs were used as hypnotics, hypnosis was a definite disadvantage
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when they were used as anxiolytics. Recent discoveries made possible the separation
between hypnotic and anxyolitic activity and selective hypnotic agents (e.g. zolpidem)
are already on the market. Selective anxiolytics are on the preclinical and/or in clinical
trial stage.
The conventional tool of computational neuroscience: a phenomenological model
One way to describe synaptic transmission is to use a gating variable similar to the well
known Hodgkin – Huxley formalism:
Isyn = g¯syns(V − Esyn) (1a)
ds
dt = αF (Vpre) (1− s) − βs (1b)
F (Vpre) =
1
1+ exp
(
Vpre −Θsyn
K
) (1c)
with Isyn being the synaptic current, g¯syn the maximal synaptic conductance, s the
gating variable of the synaptic channel, Esyn the synaptic reversal potential, F(·) is an
activation function, α and β rate functions describing opening and closing of the gate
of the synaptic channel, Θsyn is a threshold.
Figure 2. illustrates the general form of effects of GABAA receptor modulators
described by the phenomenological model, where the effect of drugs was taken into
account solely by modifying g¯syn, the maximal synaptic conductance.
[Figure 2 about here.]
From pharmacodynamics to detailed kinetic schemes
Kinetic models of transmitter-receptor interaction (without and in the presence of drugs)
help to calculate the induced synaptic current, and gives a possibility to get quantita-
tive insight how to modulate it. A specific step in the transmitter-receptor interaction,
namely desensitization, plays an important role in shaping the GABAergic currents.
Since our general goal is to incorporate appropriate kinetic models to the network
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model to compute the drug effects on global brain rhythm, we should have appropriate
kinetic model.
As opposed to the conventional phenomenological description, a more effective,
but certainly most expensive, modelling tool to evaluate the pharmacological effects
of the different modulators, or even to give help for offering new putative molecules
for drug discovery, is the inclusion of more detailed kinetic studies of GABA receptor
modulation.
Jones and Westbrook [36] established a model for describing the rapid desensiti-
zation of the GABAA receptors. More specific kinetic models should be studied to
describe the effects of the different (full and partial) agonists and antagonists taking
into account that connections between singly and doubly bound open and desensitized
states may influence the receptor kinetics. Baker et al. [37] explained the functional
difference between the effects of propofol (which has hypnotic effect) and of midazo-
lam (a sedative - amnestic drug) based on a detailed kinetic model of a single cell with
autapses and two interconnected cells.
The main difference is that propofol modifies the desensitization processes, more
dramatically the slow desensitization steps and the modified kinetic parameters. These
differences imply distinct behavior of the network (synchronization, frequency of os-
cillation) and therefore also in function.
3 Integrating receptor kinetics and neural network mod-
els
3.1 Setting up the model
In the following section we connect the two concepts reviewed in the first part of this
paper. Below is the description of an illustrative model integrating the detailed kinetic
description of synaptic receptors [9] into the biophysical model of a gamma related
theta rhythm generating interneuron network [10, 22]. We use this model to study the
effect of drugs that have a well identified effect on the chemical reactions taking place
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in the GABAA receptor.
Here, the model is introduced only briefly, detailed equations and parameters can
be found in the Appendix. The modeled interneurons contained the Hodgkin – Huxley
channels (sodium, potassium and leak), which were identical for all cells (see A-1a –
A-1m). Also, the synaptic current (Isyn(t)) and an input current (Ii(t)) were considered
(see below).
A connection between two interneurons was established through a synaptic mecha-
nism consisting of a phenomenological presynaptic and a chemically realistic described
postsynaptic part. The presynaptic model describes the transmitter release due to an ac-
tion potential generated in the presynaptic neuron by a sigmoid transfer function (see
A-2). The value of the released transmitter concentration ([L]) is then used in the post-
synaptic GABAA receptor model to calculate the concentration of receptor proteins
being in the conducting (two ligand binded open) state ([L2O](t)) (see A-3 – A-4g).
The synaptic current was thus given by
Isyn(t) =
N∑
i=1
g¯syn,i · [L2O]i(t) · (V(t) − Vsyn) (2)
where N is the number of presynaptic neurons, i indexes these presynaptic neurons,
g¯syn is the maximal synaptic conductance representing the synaptic channel density,
V(t) is the postsynaptic membrane potential and Vsyn = −75mV is the reversal po-
tential of the chloride current. For details and parameters of the postsynaptic model see
the Appendix.
Using this synaptic mechanism interneurons were connected into a random net-
work. Probability of forming a connection between any two neurons was from 60 %
to 100 % in the simulations; autapses were not allowed. Maximal synaptic strength was
normalized to enable scalability of the model: for each postsynaptic neuron
∑N
i=1 g¯syn,i = g¯syn,
where g¯syn was varied from 0.1 mS/cm2 to 0.2 mS/cm2.
As it was shown in previous computer models [10, 22] when the interneurons are
driven by periodically modulated input and the phase of inputs to different cells is
heterogeneous, the random network of interneurons generate gamma related theta fre-
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quency resonance. Indeed, as shown before by Wang and Buzsa´ki (1996) a network
of mutually interconnected fast firing inhibitory neurons can generate synchronized
gamma frequency oscillation. This synchronization is reflected e.g. in the population
activity or in the raster diagrams (for these measures see the Appendix). However,
when cells are driven by a periodic inputs with disperse phase instead of a constant
current, a slow (theta frequency range) modulation of the population activity emerges
(for details on necessary and sufficient conditions for theta generation the reader is
kindly directed to Orba´n et al. (2001)). Briefly, the input for each cell took the follow-
ing form:
Ii(t) = DC · sin(ωt+ φi) +DC (3)
with DC being the amplitude and the offset of this current (0.005 – 0.01 A/m2), ω the
frequency (25 – 50 Hz) and φi is the phase drawn from a Gaussian distribution with 0
mean and 30 degree variance.
3.2 Direct problem: in silico drug screening with the integrated
model
Kinetic modeling of synaptic transmission has a flexibility in the level of detailed de-
scription from chemical kinetic to simplified representation [38]. The development of
new pharmacological, electrophysiological and computational techniques make possi-
ble to investigate the modulatory effects of putative drugs for synaptic currents, and
consequently for local field potentials and even behavioral states. Putative drugs with
given kinetic properties can be tested in silico before (instead of?) real chemical and
biological studies.
As noted before population oscillations reflected by the EEG can be considered as
biomarkers for some brain disorders. We used our integrated model to study effects of
two known drugs, the hypnotic propofol and the sedative midazolam on the population
theta rhythm. In a previous work [22] it was shown that the population activity of the
interneuron network can be used to account for the activity of pyramidal cells, which
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can be in turn translated into EEG. Thus, to quantify our results the raster plots, a
population activity measure and its Fast Fourier Transform were used (see Appendix).
Control condition: As shown previously [10, 22] in control situation this model
exhibits spike synchronization in the gamma frequency band, which is modulated in
the theta band (Fig. 3) (for a detailed explanation of measures used below see the
Appendix). On Fig. 3A (the raster plot) each row symbolizes the spike train of a given
cell with a black dot representing the firing of an action potential. Note that firing
of the cells line up in well-synchronized columns e.g. from approximately 2.2 sec to
2.35 sec. As a result of heterogeneity in the phase of the driving current and in synaptic
contacts this high synchrony loosens, column on the raster plot are less well organized
in the 2.35 sec – 2.45 sec interval. This synchronization – desynchronization of cells is
a result of the modulation of the instantaneous frequency of individual cells (Fig. 3B
– for more details the reader is kindly referred to Orba´n et al (2001)). A qualitative
measure of the synchrony is given by the population activity (Fig. 3C) and the network
synchrony (Fig. 3D).
[Figure 3 about here.]
As argued in [22] this synchronization – desynchronization of the population activ-
ity of interneurons is transposed to principal cells of the hippocampal CA3 modulating
their firing probability in the theta band. This modulation might be reflected in the
EEG or CA3 local field potential. Thus, we propose that there is a mapping between
the FFT of the CA3 local field potential or EEG and the FFT of the simulated popula-
tion activity (Fig. 3E), which shows a peak at the theta frequency. Other peaks at higher
frequencies are related to the fast firing properties and the resulting synchronization of
the interneurons as well as the frequency of the driving current.
Drug administration: Given the detailed kinetic description of GABAA receptors
the modulation of the synaptic current due to its interaction with the drug can be simu-
lated. Moreover, in the integrated model framework an evaluation of the drug effect on
the network level can be performed.
The identification of the effect of a given drug on the kinetic rate parameters of a
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certain receptor type or subtype is a complicated and tedious undertaking. To present
the soundness of our model two known drugs were used in the simulations: propofol
and midazolam (for parameter values see the Appendix). However, a considerable ef-
fort was made to estimate the change of the rate constants due to the application of
the L838,417 compound using the chemical method of parameter estimation. Unfor-
tunately, sufficient kinetic or even pharmacodynamic data could not be found in the
public domain to obtain realistic estimation for the rate constants.
Figure 4 and 5 show effects of propofol and midazolam, respectively, on the net-
work behavior (sub-figures are the same as in Fig. 3: A: raster plot; B: the instantaneous
frequency versus time; C: the population activity versus time; D: network synchrony;
E: FFT of the population activity function). The purpose of the present paper is not to
give a detailed description and analysis of the mode of action of these drugs, thus we re-
strict ourselves to mention that while propofol prolongs deactivation of the receptor and
reduces the development of both fast and slow desensitization, midazolam facilitates
the accumulation of the receptors into the slow desensitized state, which compensates
the current resulting from slower deactivation [9]. As a result propofol enhances the
tonic synaptic current to a greater extent than midazolam, whereas propofol and mi-
dazolam produces similar changes to the time course of single inhibitory postsynaptic
currents (IPSCs) [39].
[Figure 4 about here.]
[Figure 5 about here.]
On the network level the difference that propofol and midazolam exert on the tonic
component of the synaptic current has a grave consequence. While the peak in the FFT
at approximately 4 Hz representing the theta modulation of the population activity is
still present in the case when synapses were “treated” with midazolam (Fig. 5E) it is
completely missing for the propofol “treated” case (Fig. 4E).
These findings are in concert with our earlier results [12] where we have shown
that diazepam a positive allosteric modulator of the GABAA synapses inhibited theta
oscillation. There synapses were modeled using the phenomenological technique and
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the increase of the tonic component of the synaptic current was achieved by increasing
the maximal synaptic conductance parameter, while the time constants were kept con-
stant to account for similar IPSCs. Methodologically, the approach we followed in the
integrated model is more established, as generally the maximal synaptic conductance
parameter is mostly associated with channel density in the synapse, which is not mod-
ified by the administration of the drug. Moreover, using the detailed kinetic model of
the GABAA synapse allows us to i, account for drug induced changes in the receptor in
a chemically more sound way; ii, simulate a much larger variety of situations than by
using the phenomenological model; and iii, present several possibilities (several sets of
rate constants) resulting in the same receptor behavior (a given receptor behavior might
be brought about by a non-unique set of parameters) to drug researchers who in turn
can engineer the desired molecule that is easiest to design.
4 Discussion
4.1 Design (Inverse Problem): From System Identification to Op-
timal Temporal Patterns
We have shown that in a moderately complex conductance-based model of the hip-
pocampal CA3 region theta rhythm generation can be observed and its general proper-
ties can be identified [10] These results qualify the model for consideration as a useful
tool in the hands of pharmacologists, physiologists and computational neuroscientists
to complete their repertoire of available tools in the search for efficient and specific
drugs.
[Figure 6 about here.]
Figure 6 is an oversimplified scheme offered for finding a modulator to set optimal
septo-hippocampal EEG pattern.
In order to decrease anxiety first a desired EEG pattern should be defined. Anxy-
olitics should reduce the theta amplitude (but preserve the cognitive performance and
avoiding sedative and hypnotic side effects). Computational analysis should offer a
17
kinetic scheme and the best rate constants to modulate the fixed network to minimize
the deviation from the desired “optimal pattern”. (Network architecture is supposed to
be fixed. By neglecting this assumption we should turn from neuropharmacology to
neurosurgery...) Most likely there are more than one possibilities to reach the goal, and
model discrimination and parameter estimation techniques may help to narrowing the
alternatives.
As it is known from chemical kinetics [40, 41] sensitivity analysis shows that in a
kinetic scheme there are “more and less important” components and reactions. It may
help to answer the question how to modify a given drug to change the reaction rate
constants in the desired direction – and leaving everything else intact.
4.2 Further research
The aim of the present paper is to offer conceptual and mathematical frameworks to
integrate network and receptor level descriptions for investigating the effects of po-
tential drugs on the global electrical patterns of a neural center, and on the behavioral
states (mood, consciousness, etc.). Once we have understood (i) the basic mechanisms
of rhythm generation, (ii) the elementary steps of the modulatory process, we shall be
able to give advice to drug designers pointing out which subprocess and how to be
modulated to reach the given goal.
Specifically, we briefly reviewed some aspects of GABAA receptor kinetics, and
the effects of (full and partial) agonists, antagonists and inverse antagonists to septo-
hippocampal theta rhythms. Our specific goal is to offer a computational platform to
design anxiolytic drugs with as small as possible side effects. While it is known that
positive allosteric modulators acting on GABAA α1 subunits are potential candidates
for being selective anxyolitics, integrative computational modeling would help to select
potential drugs with the appropriate kinetic properties.
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APPENDIX
Interneuron model
The interneuron model was taken from [42] and obeys the following current balance
equation:
Cm
dV
dt = −INa − IK − IL − Isyn + Ii (A-1a)
IL = gL (V − EL) (A-1b)
INa = gNam∞h (V − ENa) (A-1c)
m∞ =
αm
αm − βm
(A-1d)
αm =
−0.1 (V + 35)
exp (−0.1 (V + 35)) − 1
(A-1e)
βm =
1
exp (−0.1 (V + 28)) (A-1f)
dh
dt = φ (αh (1− h) − βhh) (A-1g)
αh = 0.07 exp
(
−(V + 58)
20
)
(A-1h)
βh =
1
exp (−0.1 (V + 28))
(A-1i)
IK = gKn
4 (V − EK) (A-1j)
dn
dt = φ (αn (1− n) − βnn) (A-1k)
αn =
−0.1 (V + 34)
exp (−0.1 (V + 34)) − 1
(A-1l)
βn = 0.125 exp
(
−(V + 44)
80
)
(A-1m)
with parameters: gL = 1 S/m2, gNa = 350 S/m2, gK = 90 S/m2, EL = −65.3mV,
ENa = 55mV, EK = −90mV φ = 5,
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Synapse model
The presynaptic model describes transmitter release due to presynaptic action poten-
tials. The following sigmoid function was used:
[L](t) =
0.003
1+ exp
(
−
Vpre(t)
2
) (A-2)
where [L](t) is the released GABA, Vpre(t) is the presynaptic membrane potential.
Our starting point for the postsynaptic model is the work of Bai et al. [9] originally
developed by Celentano and Wong [43] to describe the emergence of open channels as
the effect of GABA binding to receptors. However, we explicitly show the presence of
an essential participant of the model, the ligand L differently from in Scheme 1 of the
cited paper and our previous work [40]. Obviously, in the model the ligand L denotes
GABA, whereas L2O denotes the open channels, the notation expressing the fact that
two ligand molecules are needed to change the receptor into an open channel:
L2Dfast
df ↿⇂ rf
2kon kon ds
L+ C ⇋ L1C L+ L1C ⇋ L2C ⇋ L2Dslow
koff 2koff rs
α ↿⇂ β
L2O
(A-3)
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The induced differential equations are the followings:
[C] ′ = −2kon[L][C] + koff[L1C] (A-4a)
[L1C]
′ = 2kon[L][C] + 2koff[L2C] − (koff + kon[L])[L1C] (A-4b)
[L2C]
′ = kon[L][L1C] + rf[L2Dfast] + rs[L2Dslow] + α[L2O] (A-4c)
− (2koff + df + ds + β)[L2C] (A-4d)
[L2Dfast]
′ = df[L2C] − rf[L2Dfast] (A-4e)
[L2Dslow]
′ = ds[L2C] − rs[L2Dslow] (A-4f)
[L2O]
′ = β[L2C] − α[L2O]. (A-4g)
Furthermore, we have the following conservation equation for the total quantity of
channels in any form:
[C] + [L1C] + [L2C] + [L2Dfast] + [L2Dslow] + [L2O] = [C](0) = 1. (A-5)
Rate constants in the model were set up according to [37] to account for the control
situation, the propofol treatment and the midazolam treatment:
Rate Constants (ms−1)
Parameters Control Propofol Midazolam
kon 1000/M 1000/M 1000/M
koff 0.103 0.056 0.056
df 3.0 1.62 3.0
rf 0.2 0.12 0.2
ds 0.026 0.014 0.026
rs 0.0001 0.0001 0.0001
α 0.4 0.4 0.4
β 6.0 6.0 6.0
Data analysis
The raster plot
A raster plot is used to visualize spike-trains of neurons. To draw a raster plot, first
spiking times of neurons were identified, then time was discretized assigning a 0 or 1
22
value to each time bin depending on weather the cell emitted a spike in a given bin or
not:
t
spiking
i = {t | Vi(t) > 0∧
˙Vi(t) ≥ 0} (A-6a)
Fτi (l) =
∣∣∣tspikingi ∩ {t | lτ ≤ t < (1+ l)τ}
∣∣∣ (A-6b)
where tspikingi is the set of time points when cell i emits an action potential, Vi(t) is the
membrane potential of cell i, Fτi (l) is the spike train and τ = 5 ms is the binning width.
The instantaneous frequency
To characterize the behavior of individual cells a measure of their instantaneous fre-
quency or firing rate was calculated the difference as in [10]:
ISIi(t) = min
(
t
spiking
i ∩ t2|t2 > t
)
− max
(
t
spiking
i ∩ t1|t1 ≤ t
)
(A-7a)
fi(t) =
1
ISIi(t)
(A-7b)
The population activity measure
A “projection” of the raster plot to the time axis gives the population activity:
aτ,T
′
(t) =
1
N
N∑
i=1
[
t+T
′
τ
]
∑
l=[ tτ ]
Fτi (l) (A-8)
where N is the number of neurons, T ′ = 10 ms is a time window in which action
potentials are counted and [m] denotes the integer part of m.
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The network synchrony
The network synchrony measure was defined as follows:
κτ,T
′
(t) =
2
N(N− 1)
N∑
i=2
i−1∑
j=1
[
t+T
′
τ
]
∑
l=[ tτ ]
Fτi (l)F
τ
j (l)
√√√√√√
[
t+T
′
τ
]
∑
l=[ tτ ]
(Fτi )
2(l)
[
t+T
′
τ
]
∑
l=[ tτ ]
(Fτj )
2(l)
(A-9)
where the window width was set to T ′ = 50 ms.
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List of Figures
1 Computer model of the hippocampal CA1 circuitry. Neuron populations hypothesized to be responsible for the generation of theta oscillation are shown (pyr – pyramidal cells; i(O-LM) – horizontal cells projecting to the distal dendrites of pyramidal cells in the lacunosum moleculare layer; i(b) – basket interneurons; i(S) – septally projecting hippocampal horizontal interneurons; MS-GABA – septal GABAergic cells, triangles denote excitatory, dots inhibitory synapses). Connections originating and ending at the same population denote recurrent innervation. 31
2 Modelling the effects of allosteric GABAA receptor modulators. In a simple description of synaptic transfer the strength of synapses was modulated via the g¯syn parameter in eq. (1a) in a dose dependent manner. Inset: modelled inhibitory postsynaptic potentials before (smaller amplitude) and after (larger amplitude) administration of positive GABAA allosteric modulator. 32
3 Control activity in the model. (A), The raster plot shows the firing of all 50 neurons in the network during 1 s. When the neurons are synchronized the dots are arranged into vertical lines (e.g. at 2.8 s). The network looses its synchrony when the neurons increase their firing rate (e.g. at 2.6 s the instantaneous frequency on B is high and the raster plot is disorganized). (B), Instantaneous frequency of the neurons are in the gamma band (40-48 Hz) modulated with a slower oscillation (4 Hz, three example neurons are shown). (C), The population activity shows the proportion of neurons that fired in a 5 ms long time bin. The amplitude of the oscillation is modulated by theta. (D), The synchrony of the network is computed from the correlation of the activity of the cell-pairs in a 50 ms long time bin. (E), The Fourier spectrum of the population activity shows distinct peaks at 40 Hz (gamma frequency) and at 4 Hz (theta frequency). Note that the first second, the transient behavior of the model was omitted. Parameters used (see Appendix): number of cells: 50, g¯syn = 0.2 mS/cm2, connection probability: 0.8, ω = 37 Hz. 33
4 The effect of propofol on the activity of the modeled network. The raster plot (A) and the population activity of the network (C) show clear gamma synchrony without any slower modulation. The instantaneous frequency of the neurons is nearly constant (B). Changes in the synchrony of the network (D) are one order smaller than in control condition. The only peak in the power spectrum of the population activity (E) is at the gamma frequency. Parameters are the same as for Fig. 3. 34
5 The effect of midazolam on the network activity. Similarly to the control condition activity of the neurons are modulated with a slower, theta frequency oscillation under the effect of midazolam as shown by the the raster plot (A); the instantaneous frequency of the neurons (B); the population activity (C); the synchrony of the network (D) and the Fourier spectrum (E). Parameters are the same as for Fig. 3. 35
6 Computational neuropharmacology—an idealized method for drug discovery. See text for a description 36
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